ABSTRACT: Studies were conducted to compare continuous vs pulsatile i.v. infusion of GnRH on serum gonadotropin concentrations and ovulation in seasonally anestrous mares and in cycling mares. Anestrous mares (Exp. 1) received no treatment (control; n = 31, 2, or 20 pg of GnRH/h continuous infusion (CI) (n = 4 and n = 6, respectively), or 20 pg of GnRHh pulsatile infusion (PI) (n = 5). After initiation of GnRH infusion, serum LH levels increased earlier, and to a greater extent, in the PI group than in other groups (P c .051. In contrast, serum FSH concentrations did not differ among groups. The number of days to development of the first 35-mm follicle was not different among GnRH treatment groups; however, mares receiving PI ovulated on d 9.4 of treatment, 2.8 d earlier than those receiving 20 pg of GnRH/h CI (P c .05). Mares given 2 pg of GnRH/h CI failed to ovulate spontaneously after 16 d of treatment, but each one ovulated within 2 to 4 d after injection of 2,000 IU of hCG on d 16. Control mares did not ovulate or show any significant follicular development throughout the experiment. Cycling mares (Exp. 2) received no treatment (control; n = 61, 20 pg of GnRH/h CI, or 20 pg of GnRH/h PI (n = 4) beginning on d 16 of an estrous cycle (d 0 = day of ovulation). Serum LH concentrations in all groups increased after initiation of treatment; however, on the day of ovulation LH concentrations were lower in the CI group than in the PI or control groups (P e .05). Serum FSH was not different among groups. The GnRH treatment, however, did not alter the time to ovulation compared with controls CP > 201. We conclude that the mode of GnRH infusion (continuous vs pulsatile) differentially affects LH secretion in the mare and that the effects of the infusion pattern are influenced by the physiological state of the mare.
Introduction
Gonadotropin-releasing hormone is secreted in a pulsatile manner in most mammals, and GnRH pulse frequency is the primary regulator of LH secretion (Alexander and Irvine, 1987;  Fitzgerald et al., 1987) . Endogenous pulses of GnRH, inferred from LH pulse frequency, are absent in anestrous mares and occur approximately once every 11 h in diestrous and once per hour in estrous mares (Alexander and Irvine, 1986) . By contrast, the number of pituitary GnRH receptors does not change with respect to reproductive state or season (Hart et al., 1984;  Silvia et al., 1986) .
Therapy with GnRH has been studied as a means of inducing ovulation in seasonally anestrous mares, hastening the onset of regular cycles in transitional mares, and shortening the follicular phase in cycling mares. Previous studies of seasonally anestrous mares have shown that i.v. administration of native GnRH in a pulsatile fashion (PI; doses ranging from 2 to 250 pg/h) results in ovulation within 12 d after the start of treatment (Johnson, 1986a (Johnson, , 1987  Johnson and 
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Becker, 1988). By comparison, continuous infusion (CI) of GnRH (Hyland et al., 1987) or analogs of GnRH W e n et al., 1987; Harrison et al., 1990) via S.C. implants also induces ovulation in anestrous mares, although in a less reliable fashion and with a greater variation in response time than i.v. pulses of GnRH. In light of the apparent difference in the effectiveness of GnRH infused in a pulsatile or continuous manner to induce ovulation in acyclic mares, the present studies were conducted to compare directly the effects of a continuous vs pulsatile pattern of i.v. administration of GnRH on serum gonadotropin concentrations and ovulation in both seasonally anestrous and cycling mares.
Materials and Methods
Standardbred mares between 7 and 25 yr of age were used. Their diet consisted of seasonal pasture and mixed hay, with water and trace-mineralized salt available at all times. Mares were housed in individual box stalls for the duration of the infusion period and were exposed to ambient photoperiod throughout the experiments.
Experiment 1
Twelve mares were used during the 1989 and 1990 anestrous seasons. Six of the mares were used twice, once each season, and, with one exception, no mare received the same treatment twice. During the study, the ovaries of all mares were palpated per rectum daily and examined ultrasonically using a linear-array scanner (Technicare 210 DX, Pitman-Moore, Washington Crossing, NJ). Seasonal anestrus was defined as the absence of corpus luteum function (serum progesterone e 1.0 n g / d and the failure of ovarian follicles to develop to > 25 mm in diameter during a period of at least 5 wk before the experiment.
During February and early March mares were randomly allotted to one of four treatment groups: 11 no infusion (controls; n = 3); 2) 2 pg of GnRH/h, i.v., CI (n = 4); 31 20 pg of GnRH/h, i.v., CI (n = 6); or 4 ) 20 pg of GnRHh, i.v., PI In = 5). 
Experiment 2
Ten mares were used during the 1989 breeding season. Five of the mares were used more than once, but at least one normal estrous cycle intervened between treatments, and no mare received the same treatment twice. Beginning on d 16 of an estrous cycle, during the follicular phase (d 0 = day of ovulationl, one of three treatments was administered: 1) no infusion (controls; n = 6); 2) 20 pg of GnRH/h, i.v., CI (n = 6); or 3) 20 pg of GnRHh, i.v., PI (n = 4). Continuous infusion of GnRH was administered as in Exp. 1, except the minipump used had a shorter infusion duration (7 d) Alzet 2ML1, Alza). In all but one instance, infusion of GnRH for both groups was terminated within 24 h of ovulation. The single exception was a mare in the CI group whose pump was empty before ovulation on d 28. In all mares, day of ovulation was determined by ultrasound examination and was subsequently confirmed from serum concentrations of progesterone.
Blood samples were taken 1 d before initiation of the experiment, twice a day from the start of infusion until 1 d postovulation, and then once a day for the next 20 d (Exp. 1) or once a day until the next ovulation (Exp. 2). For the PI groups, blood was drawn midway between two pulses. Serum LH (Johnson, 1986b1, FSH (Johnson, 19871, and progesterone (Malinowski et al., 19851 were determined by RIA. The mean within-assay CV for the LH, FSH, and progesterone assays were 19.3, 28.1, and 9.6%, respectively. Ovulation of a follicle was determined according to criteria outlined by Ginther (1986). Total number of synchronous ovulations was taken as that number of follicles ovulated within 24 h of the fist ovulation (Ginther, 1986) .
Ovulation data and hormonal profiles for the various treatment groups of Exp. 1 were found not to differ between the 2 y r (compared by ANOVA); consequently, data from both years were combined. Follicle and ovulation data, as well as LH concentrations on the day of ovulation, were analyzed by a one-way ANOVA LANOVA 11, Human Systems Dynamics, Northridge, CAI, and signifkant differences were partitioned by the Newman-Keds multiple range test. Hormone data within a treatment group, over time, were analyzed by an ANOVA for repeated measures (SAS, 1985). Because of the similarity in hormone concentrations of the twice-daily (morning and afternoon) blood samples, only the morning samples were used for statistical analysis. Area under the curve, as calculated from the series of trapezoids formed from each time interval vs the net increase in hormone, was used to determine total LH or progesterone secreted over time for each treatment group. The baseline used for calculating the area under the curve was the LH concentration in the sample immediately before initiation of infusion for each mare, or the progesterone concentration on the day of ovulation. The resulting areas were analyzed by a one-way ANOVA, followed by the Neuman-Keuls multiple range test. In addition, serum FSH concentrations just before initiation of infusion and on the day before ovulation were compared using a Student's paired t-test. Finally, regression analysis was used to determine the relationship between size of a follicle immediately before ovulation, irrespective of treatment, and the day of ovulation (Exp. 2). 
Results
Experiment 1
After initiation of GnRH infusion, serum LH concentrations increased earlier, and to a greater extent, in the PI group than in the other groups, as determined either by repeated measures ANOVA ( P c .05) or by area under the curve (23.1 f 4.5 ng.mL-'-d-' vs 8.3 f 2.8, .a f .4, and .4 f .4 ng.mL-l .d-' for 20 and 2 pg/h CI and control groups, respectively; P e .05; Figure 1 ). Luteinizing hormone concentrations over time, as determined by repeated measures ANOVA, were not significantly different among the 2 and 20 pg/h CI treatments and the control treatment. When LH values were aligned relative to the day of ovulation, mares receiving PI had greater LH levels than mares in the CI groups, whether analyzed by repeated measures ANOVA Ip e .05) or by area under the curve (3.9 f 1.4, 16.6 f 4.8, and 40.7 f 5.0 ng.mL-'.d-l for 2 and 20 pg/h CI and 20 pg/h PI, respectively; P c .05; Figure 2 ). On the day of ovulation, serum LH concentrations were not different between the CI groups (1.5 f .5 vs 3.9 f 2.5 ng/mL for 2 and 20 pg/h doses, respectively; P The pooled SEM is .93 and 15.14 ng/mL for LH and FSH, respectively. > 201, whereas the mean LH concentration for the PI group (6.8 f 1.2 ng/mL) was greater than that for the 2 pg/h CI group (P < .05).
Because of large variability in serum FSH concentrations, both within a mare and within a group, no significant differences were detected among treatment groups over time for FSH values aligned relative to either the day of the experiment (Figure 1) or the day of ovulation (Figure 2) . However, for all GnRH-infusion groups combined, FSH levels were lower on the day before ovulation than just before initiation of infusion (P = .005). Pulsatile infusion of GnRH resulted in enhanced progesterone secretion during the subsequent luteal phase compared with the 2 and 20 pg/h CI groups, whether analyzed by repeated measures ANOVA (P < .05) or by area under the curve (58.5 & 9.3, 7 9 . 5 f 9.2, and 153.3 f 18.5 ng.mL-l-d-l for 2 and 20 pg/h CI and 20 pg/h PI, respectively; P < .05; Figure 3) .
Control mares failed to ovulate or show any significant follicular development throughout the experimental period [ Table 1 
Experiment 2
Serum LH levels in all groups increased after d 16 ( Figure 4) ; however, on the day of ovulation, LH concentrations, as analyzed by a one-way ANO-VA, were lower in the CI group 11.8 f .9 and 8.3 f .6 ng/mL for PI and control groups, respectively; P < .05), as were LH levels over time, as determined by repeated measures ANOVA (P < .05; Figure 5) ng.mL-'.d-' for control, 20 pg/h CI, and 20 pg/h PI, respectively P = .086). Because of considerable variation in serum FSH concentrations, both within a mare and within a group, no significant interactions were found among treatment groups over time for FSH values aligned relative to either day of the cycle (Figure 4) or to day of ovulation (Figure 5) . Nevertheless, in all groups, FSH levels decreased during the follicular phase (Figure 41 , and, for all groups taken as a whole, were lower on the day before ovulation than before infusion on d 16 CP = .021). Profiles of serum progesterone concentrations after the treatment ovulation were similar among the groups (P > .20, Figure 6) .
Treatment with GnRH did not alter either the time to ovulation or the number of ovulations compared with controls (P > 20; Table 2 ). A significant correlation was found across treatment groups between the size of the follicle immediately before ovulation and the day of ovulation Cy = 2.11X + 13.39; r = .59, df = 17; P = .007).
Discussion
Results from Exp. 1 demonstrate that although both pulsatile and continuous infusion, i.v., of GnRH can induce follicular development in seasonally anestrous mares, the pulsatile mode of delivery induces ovulation in a shorter period of time. Ovulation occurred in 9.4 k .7 d in the PI group (Table 11 , which is comparable to results previously reported using 20 p g h of GnRH (mean of 11.6 d in 17 of 17 mares; Johnson, 1987; (Hyland et al., 1987) . In the present study, CI of 20 pg/h, i.v., resulted in ovulation in six of six mares in 12.2 f .7 d; thus, we suggest that i.v. CI of GnRH is comparatively more efficient in achieving a greater success rate over a shorter duration than S.C. CI of GnRH.
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Intravenous CI of 2 pg/h failed to induce spontaneous ovulation after 16 d of treatment, yet an equivalent dose administered in a pulsatile fashion has previously been reported to result in ovulation in six of six mares in one study (Johnson, 19871 and eight of nine mares in a second study (Johnson and Becker, 19881 , with an overall mean time to ovulation of 10.8 d. Such results suggest that higher doses of GnRH are needed when infusing in a continuous vs pulsatile manner.
Only one of the continuously infused mares simultaneously ovulated more than a single follicle (two follicles were ovulated in one mare from the 2 pg/h group), whereas only two of five mares in the PI group double-ovulated. The ovulatory response to 20 pg/h PI was lower than previously reported (the same treatment induced two or more ovulations in 8 of 10 mares; Johnson and Becker, 1988). Moreover, Ginther and Bergfelt (1990) reported that twice-daily injections, i.m., of a GnRH analog induced multiple ovulations (two or three ovulations per mare) in 27 of 86 (31%) seasonally anestrous mares. Clearly, additional work is needed to define adequately conditions that will reliably enhance the number of ovulations in seasonally anestrous mares.
The comparatively greater effectiveness of PI, compared with 20 pg/h CI, to induce ovulation is likely related to its ability to stimulate a greater rise in serum LH concentrations. In fact, LH levels in the CI groups were not signifcantly different from those in the control group, and this is similar to other results (Hyland et al., 1987) that showed that 50 n g . k g l .h-l CI did not increase serum LH compared with controls. However, the LH increase resulting from 20 pg of GnRH/h CI was sufficient to cause ovulation in six of six mares. It is also of interest to note 1) that significant follicular development occurred in mares receiving 2 p g k CI, despite the fact that neither serum LH nor FSH concentrations were increased significantly compared with control values and 2) that ovulation was induced in all mares in the 2 pg/h CI group subsequent to hCG treatment. Large variability in serum FSH concentrations precluded detecting any significant differences among groups. However, in individual mares, irrespective of GnRHtreatment group, FSH levels declined after the 2nd d of infusion compared with control levels ( Figure  1 ). This decline might reflect the growing number of follicles in response to GnRH, which could be capable of secreting inhibin and(or1 estradiol to inhibit FSH secretion from the pituitary (Burns and Douglas, 1981; Miller et al., 1981; deJong and Robertson, 1985; Piquette et al., 1990) . Finally, progesterone profiles for all treatment groups were indicative of a normal luteal phase, both with respect to onset and duration of progesterone secretion (Ginther, 1979) . However, PI of GnRH resulted in higher serum progesterone concentrations than CI, which could be advantageous for the maintenance of early pregnancy.
Results from Exp. 2 show that CI of GnRH beginning on d 16 suppressed endogenous LH secretion in cycling mares without altering the day on which ovulation occurred. Pulsatile infusion of GnRH caused no significant increase in LH concentrations over control values and did not alter the time to ovulation. This observation is in apparent contrast to a previous report from our laboratory in which 20 pg/h PI beginning d 16 of the estrous cycle advanced the time of ovulation by 3 d compared with controls (Johnson, 1986b) . However, this discrepancy may be attributed to the relatively small number of mares treated with PI in the present study. Nevertheless, in keeping with this previous study (Johnson, 1986b1 , PI did not result in elevated serum LH levels compared with control mares (Figure 5) .
Infusion of GnRH, regardless of pattern, failed to enhance the number of ovulations over that in the control group ( Table 2) . This lack of effect of GnRH treatment on ovulation rate is consistent with a previous report (Squires et al., 19891 and may be the result of inhibitory actions on FSH release by estradiol and(or1 inhibin, either of which could be produced by follicles present in the ovaries on d 16 when GnRH treatment was initiated. In support of this proposal is the finding (Pierson and Ginther, 1987) . The significant correlation between the size of the follicle, immediately before ovulation, and the day of ovulation is consistent with the observation by Ginther (1979) that the greater the maximum diameter reached by the follicle, the longer the interval from the 1st d of estrus to ovulation.
Finally, we have previously noted that prolonged, pulsatile GnRH treatment during anestrus (Johnson, 1986a (Johnson, , 1987 and the breeding season fails to down-regulate LH secretion from the mare pituitary. By contrast, results from the present study clearly indicate that CI of GnRH, i.v., during the follicular phase attenuates the endogenous LH surge (Figure 5 ). This latter fiiding is similar to those from studies with anestrous sheep (Chakraborty et al., 1974) and cycling cattle (Kinder et al., 1975; Milvae et al., 1984) in which prolonged exposure to GnRH resulted in a decrease in pituitary responsiveness to GnRH and lower serum LH concentrations.
Implications
Pulsatile, intravenous infusion of gonadotropinreleasing hormone (GnRH) may be indicated for select, clinical application in mares because it reliably induces follicular growth and ovulation during seasonal anestrus and results in enhanced progesterone secretion, which could be advantageous for the maintenance of early pregnancy. Continuous, but not pulsatile, i.v. infusion of GnRH seems to down-regulate pituitary luteinizing hormone secretion during the breeding season, yet at 20 pg/h neither regimen affects follicular development or time of ovulation. Higher doses administered continuously might inhibit ovulation. Any future treatment regimens using GnRH, or analogs of GnRH, administered in a continuous fashion to improve the reproductive efficiency of broodmares should be carefully evaluated, with regard to season and reproductive state, for their effects on gonadotropin secretion.
